Dr. Colleen M Deuel, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Route 36 Sonyea Road, State Of New York Dept Health, Sonyea, NY 14556 Phone: 585-658-3710 |
News Archive
The Baylor College of Medicine Human Genome Sequencing Center has standardized its target enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology. The Baylor HGSC will sequence over 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases and will employ NimbleGen SeqCap EZ Exome and customized NimbleGen exome designs as the exome capture technology of choice. More than 15 different diseases will be investigated by Baylor HGSC, including brain, liver, pancreatic, colon, ovarian and bladder cancers, heart disease, diabetes, autism, and other inherited diseases with the goal of better understanding causative mutations and their impact on these diseases.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
In what may be the largest survey of physician attitudes about firearms and how firearm-owning surgeons store guns in their homes, U.S. members of the American College of Surgeons (ACS) said they support the organization taking an active role in advocating for policies and programs designed to lower the risk of firearm-related injuries and deaths.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.
› Verified 7 days ago